The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Essential Responsibilities
Education & Experience
Physical & Travel Requirements:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
DescriptionThe Opportunity : Live and work in THE LAND OF ENCHANTMENT . CHRISTUS St. Vincent Regional Medical Center, located... ..., paid time off (PTO) package, annual CME allowance, a retirement savings plan with employer contribution, and employer-paid medical...
...Candidates should be ready to work under diverse weather conditions and handle tasks both in and around marine equipment like dredge barges and push boats. This role demands rigorous field engagement and is suited for individuals who thrive in challenging environments....
...About ARCHIMED ARCHIMED is a global investment firm dedicated exclusively to the healthcare... ...KA Foundation. The Opportunity Private equity is not a profession defined by routine,... ...others see noise. As a Private Equity Intern , you will step into this world and...
...care through technological innovation, medical expertise, and collective intelligence. About the role As a key member of the team QA, your main mission is to contribute with your QA expertise to make our product more robust and quality-oriented. For that, you will...
.../professional organizations; while supporting our mission, strategy, and values. This is a full-time position located in either Hershey, PA or Lancaster, PA. Minimum Qualification: Must have College degree. Must have 10 years of experience in a trust department...